Search

everythinglearnresearchcommunity

for

Search:↓

The oncoprotein causes abnormal hair growth without increasing skin cancer risk.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Stat3 influences keratinocyte stem cell behavior, affecting differentiation and migration.

A heart transplant patient developed a skin condition called epidermodysplasia verruciformis after taking immune-suppressing drugs.

Increased ODC activity leads to skin tumors by recruiting stem cells, not by toxic byproducts.

Mutant MK6a transgenes in mice cause blistering, hair loss, and potential human alopecia.

A gene deletion causes the "hairless" trait in Iffa Credo rats.

EdnrB signaling helps melanocyte stem cells regenerate and could be targeted to treat pigmentation issues.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

A new genetic variant of Woodhouse-Sakati syndrome was found in two adult sisters in Russia.

TCF/Lef1 is essential for skin barrier function by regulating lipid metabolism.

Akt2 and SGK3 are both important for normal hair growth and development.

Targeting ATM could help manage heart cell enlargement due to pressure overload.

The hr gene is linked to hair loss in Valle del Belice sheep.

Biotin supplements improved skin and hair problems in a girl with biotinidase deficiency.

Meis1 is crucial for skin health and tumor development.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

A 38-year-old man was diagnosed late with Kearns-Sayre syndrome after being wrongly treated for epilepsy.

Lack of certain fatty acids causes skin, immune, and fertility issues in mice.

A young patient with unusual insulin resistance and high testosterone levels had a rare INSR gene mutation.

Mutations in keratin genes cause skin disorders, but new treatments show promise.

FOXN1 mutations can cause varying immune and physical issues, with severity influenced by gene activity and possibly other factors.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

DMBT1 and galectin-3 may help suppress epithelial skin cancer.

A specific gene variant causes severe skin issues and increases infection risk, requiring careful medical monitoring.

Mutations in keratin genes cause cell fragility and various skin disorders.

The enzyme RDH12 plays a role in vision and retinal disease, with mutations leading to early onset visual loss and blindness, but the exact disease mechanism is unclear and there are no treatments yet.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.

Selenium in proteins helps prevent over-oxidation and supports chemical reversibility.